Verrica Pharmaceuticals Inc. (VRCA)

NASDAQ

$4.16

$--

(0.00%)

Pre-Market

Verrica Pharmaceuticals Inc. (VRCA) Live Price Chart

Last updated: ⁦2026-10-12 10:26:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Verrica Pharmaceuticals Inc. (VRCA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.16, with a market capitalization of $70.60M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.28 to $9.82. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$70.60M
Open	$4.16
Day's High	$232.90
Day's Low	$3.28
Previous Close	$4.11
Volume	--
Average Volume	63.95K
P/E Ratio	--
52-Week High	$9.82
52-Week Low	$3.28
Dividend Yield	--
Earnings Date	--

Verrica Pharmaceuticals Inc. (VRCA) Pre-Market Stock Price

Verrica Pharmaceuticals Inc. (VRCA) is trading at $4.16 in pre-market trading as of 2026-10-12 08:01:00, up 1.19% ($0.05) from the previous close of $4.11

Pre-market trading shows how investors are pricing VRCA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Verrica Pharmaceuticals Inc. (VRCA) 7-Day Stock Price Change

Over the past seven days, Verrica Pharmaceuticals Inc. (VRCA) moved from $4.52 to $4.16, representing a decline of 7.88% ($0.36).

The stock traded between $4.05 and $4.85 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 43.97 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

VRCA 52-Week Price Position

Position in Range: 13.4%

52W Low$3.28

52W High$9.82

VRCA is currently trading at $4.16, placing it 13.4% of the way from its 52-week low of $3.28 to its 52-week high of $9.82. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Verrica Pharmaceuticals Inc. (VRCA)?

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Verrica Pharmaceuticals Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	76
Exchange	NASDAQ
Company Website	https://www.verrica.com

How to Buy Verrica Pharmaceuticals Inc. (VRCA) Stock on MEXC

Eligible investors can buy real shares of Verrica Pharmaceuticals Inc. (VRCA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VRCA and Place Your Order

Open the RealStocks trading page and search for VRCA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Verrica Pharmaceuticals Inc. (VRCA) stock price today?

Verrica Pharmaceuticals Inc. (VRCA) is currently trading at $ 4.16, up 1.19% ($0.05) from the previous close of $ 4.11. Intraday prices update in real time during regular trading hours.

2.Is VRCA stock going up or down today?

As of 2026-10-12 08:01:00, VRCA is trading at $ 4.16, up 1.19% ($0.05) from its previous close of $ 4.11. The stock has traded between $ 3.28 and $ 232.90 during today’s regular session. Past price movements do not guarantee future results.

3.What is VRCA pre-market price?

As of 2026-10-12 08:01:00, VRCA is trading at $ 4.16 in pre-market trading, up 1.19% ($0.05) from the previous close of $ 4.11. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VRCA after-hours price?

As of 2026-10-12 08:01:00, VRCA is trading at $ 4.16 in after-hours trading, up 1.17% ($0.05) from the regular-session close of $ 4.11. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is VRCA stock trading now?

VRCA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VRCA sit relative to its 52-week high and low?

Over the past 52 weeks, VRCA has traded between a low of $ 3.28 and a high of $ 9.82. At $ 4.16, the stock is positioned 13.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Verrica Pharmaceuticals Inc. in?

Verrica Pharmaceuticals Inc. (VRCA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Verrica Pharmaceuticals Inc.'s market capitalization and where is it listed?

Verrica Pharmaceuticals Inc. is listed on the NASDAQ exchange with a market capitalization of $ 70.60M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VRCA valued in terms of P/E ratio and EPS?

VRCA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.82. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Verrica Pharmaceuticals Inc. pay a dividend?

Verrica Pharmaceuticals Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.